Results 31 to 40 of about 692,714 (305)

Biofilms and Mycobacterium tuberculosis [PDF]

Infection and Immunity, 2017
There is good evidence that Mycobacterium tuberculosis evolved with Homo sapiens and, like our ancestors, migrated throughout the rest of the world from Africa some 70,000 years ago ([1][1]). Since M.
openaire   +2 more sources

How mycobacterium tuberculosis infection could lead to the increasing risks of chronic fatigue syndrome and the potential immunological effects: a population-based retrospective cohort study

Journal of Translational Medicine, 2022
Background Chronic fatigue syndrome (CFS) has been shown to be associated with infections. Tuberculosis (TB) is a highly prevalent infectious disease. Patients with chronic fatigue syndrome and post-tuberculosis experience similar symptoms.
Tse-Yen Yang, Cheng-Li Lin, Wei-Cheng Yao, Chon-Fu Lio, Wen-Po Chiang, Kuan Lin, Chien-Feng Kuo, Shin-Yi Tsai   +7 more
doaj   +1 more source

Immunity toMycobacterium tuberculosis [PDF]

Clinical and Developmental Immunology, 2011
Tuberculosis (TB) remains a major cause of mortality and morbidity worldwide. Currently, a third of the world's population is infected with Mycobacterium tuberculosis, the causative agent of TB, and annually there are 10 million new cases of clinical TB and approximately 2 million deaths [1]. TB kills more individuals each year than any other bacterial
Triccas, James A., Winter, Nathalie, Feng, Carl G., West, Nicholas P.   +3 more
openaire   +7 more sources

Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents

New England Journal of Medicine, 2018
BACKGROUND Recent Mycobacterium tuberculosis infection confers a predisposition to the development of tuberculosis disease, the leading killer among global infectious diseases.
E. Nemes, H. Geldenhuys, V. Rozot, Kathryn Tucker Rutkowski, F. Ratangee, N. Bilek, Simbarashe Mabwe, Lebohang Makhethe, Mzwandile Erasmus, Asma Toefy, H. Mulenga, W. Hanekom, S. Self, L. Bekker, R. Ryall, S. Gurunathan, C. Diazgranados, P. Andersen, Ingrid Kromann, Thomas Evans, R. Ellis, Bernard S Landry, D. Hokey, R. Hopkins, A. Ginsberg, T. Scriba, M. Hatherill   +26 more
semanticscholar   +1 more source

The Mycobacterium tuberculosis Phagosome [PDF]

, 2008
Tuberculosis is currently the most devastating human bacterial disease, causing millions of deaths annually and infecting an overwhelming percentage of the global population. Its success as a scourge lies in the ability of Mycobacterium tuberculosis to prevent normal phagolysosome biogenesis, essential to the destruction of invading microorganisms ...
Esteban A, Roberts, Vojo, Deretic
openaire   +2 more sources

Evaluation of the Presence and Viability of Mycobacterium bovis in Wild Boar Meat and Meat-Based Preparations

Foods, 2021
The aim of the present study is to provide information about the ability of Mycobacterium bovis to survive within wild boar (Sus scrofae) meat and meat-based preparations and the duration of this survival, and to consider the preservation of its ...
Maria T. Clausi, Lucia Ciambrone, Mariagrazia Zanoni, Nicola Costanzo, Maria Pacciarini, Francesco Casalinuovo   +5 more
doaj   +1 more source

The Immune Escape Mechanisms of Mycobacterium Tuberculosis

International Journal of Molecular Sciences, 2019
Epidemiological data from the Center of Disease Control (CDC) and the World Health Organization (WHO) statistics in 2017 show that 10.0 million people around the world became sick with tuberculosis.
Weijie Zhai, Fengjuan Wu, Yiyuan Zhang, Yurong Fu, Zhijun Liu   +4 more
semanticscholar   +1 more source

In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates

Microbiology Spectrum
Non-tuberculosis mycobacteria (NTM), particularly Mycobacterium abscessus subsp. abscessus (M. abscessus), are increasingly being recognized as etiological agents of NTM pulmonary disease. However, treatment options for M.
Izumi Yamatani, Akio Aono, Keiji Fujiwara, Takahiro Asami, Keisuke Kamada, Yuta Morishige, Yuriko Igarashi, Kinuyo Chikamatsu, Yoshiro Murase, Hiroyuki Yamada, Akiko Takaki, Kosaku Komiya, Satoshi Mitarai   +12 more
doaj   +1 more source

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing

mBio, 2017
The Xpert MTB/RIF assay (Xpert) is a rapid test for tuberculosis (TB) and rifampin resistance (RIF-R) suitable for point-of-care testing. However, it has decreased sensitivity in smear-negative sputum, and false identification of RIF-R occasionally ...
S. Chakravorty, A. Simmons, M. Rowneki, Heta Parmar, Yuan Cao, J. Ryan, P. Banada, Srinidhi Deshpande, S. Shenai, A. Gall, J. Glass, Barry Krieswirth, S. Schumacher, P. Nabeta, N. Tukvadze, C. Rodrigues, A. Skrahina, E. Tagliani, D. Cirillo, A. Davidow, C. Denkinger, D. Persing, R. Kwiatkowski, Martin Jones, D. Alland   +24 more
semanticscholar   +1 more source

Microevolution ofMycobacterium tuberculosisin a Tuberculosis Patient [PDF]

Journal of Clinical Microbiology, 2010
ABSTRACTFiveMycobacterium tuberculosisisolates were obtained from three body sites from a Dutch patient. The isolates displayed a single genotype by 24-locus MIRU-VNTR typing (except for a single locus not amplified from one isolate) but were differentiated by small variations in IS6110fingerprints, spoligotypes, 6 hypervariable MIRU-VNTR loci, and/or ...
Al-Hajoj, SAM, Akkerman, O, Parwati, I, Al-Gamdi, S, Rahim, Z, van Soolingen, D, van Ingen, J, Supply, P, van der Zanden, AGM   +8 more
openaire   +5 more sources